Lgl Partners, LLC Cogent Biosciences, Inc. Transaction History
Lgl Partners, LLC
- $636 Million
- Q4 2024
A detailed history of Lgl Partners, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Lgl Partners, LLC holds 14,500 shares of COGT stock, worth $134,125. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,500
Previous 14,500
-0.0%
Holding current value
$134,125
Previous $156,000
27.56%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding COGT
# of Institutions
174Shares Held
114MCall Options Held
56.7KPut Options Held
40.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$96.9 Million0.31% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.24MShares$85.5 Million8.19% of portfolio
-
Commodore Capital LP New York, NY7.54MShares$69.7 Million6.92% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$67.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$64.4 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $608M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...